Therapeutic time window for conivaptan treatment against stroke-evoked brain edema and blood-brain barrier disruption in mice

BACKGROUND: Ischemic stroke is often complicated by brain edema, disruption of blood-brain barrier (BBB), and uncontrolled release of arginine-vasopressin (AVP). Conivaptan, a V1a and V2 receptor antagonist, reduces brain edema and minimizes damage to the blood-brain barrier after stroke. Most strok...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeynalov, Emil, Jones, Susan M., Elliott, J. Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576654/
https://www.ncbi.nlm.nih.gov/pubmed/28854286
http://dx.doi.org/10.1371/journal.pone.0183985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576654/
https://www.ncbi.nlm.nih.gov/pubmed/28854286
http://dx.doi.org/10.1371/journal.pone.0183985

Ejemplares similares